Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/9842
Title: Time to tracheal extubation after coronary artery surgery with isoflurane, sevoflurane, or target-controlled propofol anesthesia: a prospective, randomized, controlled trial.
Authors: Parker, Francis C;Story, David A;Poustie, Stephanie J;Liu, Guoming;McNicol, Larry
Affiliation: Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia.
Issue Date: 1-Oct-2004
Citation: Journal of Cardiothoracic and Vascular Anesthesia; 18(5): 613-9
Abstract: To determine if anesthesia with sevoflurane or target-controlled propofol reduced the time to tracheal extubation after coronary artery bypass graft surgery compared with isoflurane anesthesia.A 3-arm (isoflurane, sevoflurane, or propofol), randomized, controlled trial with patients and intensive care staff blinded to the drug allocation.A single, tertiary referral hospital affiliated with the University of Melbourne.Three hundred sixty elective coronary artery surgery patients.Patients received either isoflurane (control group, 0.5%-2% end-tidal concentration), sevoflurane (1%-4% end-tidal concentration), or target-controlled infusion of propofol (1-8 microg/mL plasma target concentration) as part of a balanced, standardized anesthetic technique including 15 microg/kg of fentanyl.The primary outcome was time to tracheal extubation. The median time to tracheal extubation for the propofol group was 10.25 hours (interquartile range [IQR] 8.08-12.75), the sevoflurane group 9.17 hours (IQR 6.25-11.25), and the isoflurane group 7.67 hours (IQR 6.25-9.42). Intraoperatively, the propofol group required less vasopressor (p = 0.002) and more vasodilator therapy (nitroglycerin p = 0.01, nitroprusside p = 0.002). There was no difference among the groups in time to intensive care unit discharge.The median time to tracheal extubation was significantly longer for the target-controlled propofol group. A significantly greater number in this group required the use of a vasodilator to control intraoperative hypertension.
Internal ID Number: 15578473
URI: http://ahro.austin.org.au/austinjspui/handle/1/9842
URL: http://www.ncbi.nlm.nih.gov/pubmed/15578473
Type: Journal Article
Subjects: Aged
Analgesics.therapeutic use
Anesthetics, Inhalation.therapeutic use
Anesthetics, Intravenous.blood.therapeutic use
Coronary Artery Bypass.methods
Female
Hemodynamics.drug effects
Humans
Intensive Care Units
Intubation, Intratracheal.methods.statistics & numerical data
Isoflurane.therapeutic use
Length of Stay.statistics & numerical data
Male
Methyl Ethers.therapeutic use
Middle Aged
Postoperative Period
Propofol.blood.therapeutic use
Prospective Studies
Time Factors
Treatment Outcome
Vasodilator Agents.therapeutic use
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.